Autoantibody Release in Children after Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
Multisystem inflammatory syndrome (MIS) is a new systemic inflammatory acute onset disease that mainly affects children (MIS-C) and, at a lesser frequency, adults (MIS-A); it typically occurs 3–6 weeks after acute SARS-CoV infection. It has been postulated and shown in adults that MIS may occur afte...
Saved in:
Main Authors: | Reiner Buchhorn, Carlotta Meyer, Kai Schulze-Forster, Juliane Junker, Harald Heidecke |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/2bd91cc185834d0abdb615b809d7ce73 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
by: Megan Striha, et al.
Published: (2021) -
Paediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Infection: A Case Series
by: Aneesha Mathew, et al.
Published: (2021) -
A fine line between macrophage activation syndrome and multisystem inflammatory syndrome in children – literature review based on two case reports
by: Agnieszka Poniecka, et al.
Published: (2021) -
Hashimoto's Thyroiditis: Lingual and Labial Capillary Microcirculation in Patients Affected by Macroglossia
by: Scardina,G. A., et al.
Published: (2007) -
Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study
by: Mikhail M. Kostik, et al.
Published: (2021)